BREAST CANCER The 21-gene recurrence score - biology remains at the forefront

被引：3
|
作者：
Puhalla, Shannon L. [1 ]
Davidson, Nancy E. [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Dept Med, 5150 Ctr Ave, Pittsburgh, PA 15232 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2016年 / 13卷 / 08期
关键词：
DISTANT RECURRENCE; EXPRESSION; THERAPY; WOMEN; RISK;
D O I：
10.1038/nrclinonc.2016.98
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The 21-gene recurrence score is a genetic assay developed to estimate the likelihood of distant recurrence in patients with oestrogen-receptor-positive, lymph-node-negative breast cancer treated with adjuvant endocrine therapy. Now, two studies explore how the 21-gene recurrence score has been used to inform treatment decisions in this setting and beyond.
引用
收藏
页码：470 / 472
页数：2
相关论文
共 50 条
  • [21] The Relationship between Recurrence Score of 21-Gene Assay and Clinicopathological Factors of Breast Cancer
    Woolf, K.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Schiffhauer, L. M.
    Skinner, K.
    Tang, P.
    MODERN PATHOLOGY, 2010, 23 : 79A - 79A
  • [22] Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer
    Montemurro, Filippo
    Marchio, Caterina
    Sapino, Anna
    JAMA ONCOLOGY, 2020, 6 (04) : 584 - +
  • [23] The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis
    Turashvili, Gulisa
    Brogi, Edi
    Morrow, Monica
    Hudis, Clifford
    Dickler, Maura
    Norton, Larry
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (01) : 65 - 76
  • [24] The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer with Favorable Prognosis
    Turashvili, Gulisa
    Brogi, Edi
    Morrow, Monica
    Wiszowaty, Alicja
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    LABORATORY INVESTIGATION, 2017, 97 : 74A - 74A
  • [25] Comprehensive association analysis of 21-gene recurrence score and overweight in breast cancer patients
    Tong, Yiwei
    Gao, Weiqi
    Wu, Jiayi
    Zhu, Siji
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Shen, Kunwei
    Chen, Xiaosong
    CANCER RESEARCH, 2021, 81 (04)
  • [26] Recurrence Score of 21-Gene Assay Is Correlated with a Panel of Immunopathological Factors of Breast Cancer
    Subik, K.
    Delaney, A.
    Wang, J.
    Wang, X.
    Schiffhauer, L. M.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Hicks, D. G.
    Tang, P.
    MODERN PATHOLOGY, 2010, 23 : 74A - 74A
  • [27] What Is the Value of the 21-Gene Recurrence Score?
    Brauchli, Peter
    Thuerlimann, Beat
    Crowe, Susanne N.
    Herrmann, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (32) : E671 - E672
  • [28] Economic impact of 21-gene recurrence score testing on early stage breast cancer in Ireland
    Smyth, L.
    Watson, G.
    Kelly, C. M.
    Keane, M.
    Kennedy, M. J.
    O'Reilly, Seamus
    O'Connor, M.
    Verleger, K.
    O'Reilly, Susan
    Walshe, J. M.
    BREAST, 2015, 24 : S113 - S113
  • [29] Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer Reply
    Sparano, Joseph A.
    JAMA ONCOLOGY, 2020, 6 (04) : 586 - 586
  • [30] Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer
    Alkushi, Abdulmohsen
    Omair, Ahmad
    Arabi, Haitham
    Masuadi, Emad
    Abualkhair, Omalkhair
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2020, 14
12345